¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"macular leprosy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • macular heterotopia
    Ȳ¹Ýµý°÷Áõ, Ȳ¹ÝÀ̼ÒÁõ
  • macular hole
    Ȳ¹Ý¿ø°ø
  • macular hypoplasia
    Ȳ¹ÝÇü¼ºÀúÇÏÁõ
  • macular pucker
    Ȳ¹ÝÁÖ¸§
  • macular reflex
    Ȳ¹Ý¹Ý»ç
  • macular sparing
    Ȳ¹Ýº¸Á¸
  • macular sparing homonymous hemianopsia
    Ȳ¹Ýº¸Á¸µ¿Ãø¹Ý¸Í, Ȳ¹Ýº¸Á¸°°ÀºÂʹݸÍ
  • macular splitting
    Ȳ¹Ý½Ã¾ßºÐÇÒ, ÁÖ½ÃÁ¡ºÐÇÒ
  • perifollicular macular atrophy
    ÅÐÁýÁÖÀ§¹ÝÁ¡À§Ãà
  • senile disciform macular degeneration
    ³ë³â¿ø¹ÝȲ¹Ýº¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • senile disciform macular degeneration
    ³ë³â±â¿ø¹ÝȲ¹Ýº¯¼º
  • macular eruption
    ¹ÝÁ¡¹ßÁø
  • macular erythema
    ¹ÝÁ¡È«¹Ý
  • macular evasion
    Ȳ¹ÝȸÇÇ, ½Ã¾ßȸÇÇ
  • macular heterotopia
    Ȳ¹Ýµý°÷Áõ, Ȳ¹ÝÀ̼ÒÁõ
  • macular hole
    Ȳ¹Ý¿ø°ø
  • macular hypoplasia
    Ȳ¹ÝÇü¼ºÀúÇÏÁõ
  • macular
    ¹Ý»ó-
  • macular pucker
    Ȳ¹ÝÁÖ¸§
  • macular reflex
    Ȳ¹Ý¹Ý»ç
  • macular sparing
    Ȳ¹Ýº¸Á¸, ÁÖ½ÃÁ¡º¸Á¸
  • macular splitting
    Ȳ¹Ý½Ã¾ßºÐÇÒ, ÁÖ½ÃÁ¡ºÐÇÒ
  • macular star
    Ȳ¹Ýº°, º°È²¹Ý»ïÃâ¹°
  • macular cherry-red spot
    Ȳ¹Ý¾ÞµÎ¹ÝÁ¡, Ȳ¹Ý¼±È«»ö¹ÝÁ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • leprosy,lepromatous
    ³ªÁ¾¸ð¾ç(ÑÛðþÙ¼åÆ)
  • leprosy,tuberculoid
    °áÇÙ¸ð¾ç(Ì¿ú·Ù¼åÆ)
  • leprosy<³ª> lepra
    ³ª, ³ªº´(ÑÛÜ»).
  • leprosy<³ª> lepra
    ³ª, ³ªº´(ÑÛÜ»).
  • leprosy<³ª> lepra
    ³ªº´
  • major tuberculoid leprosy
    ´ë°áÇپ糪(ÓÞÌ¿ ú·åÆÑÛ).
  • multibacillary leprosy
    ´Ù±Õ³ª
  • mutilating leprosy ³ª lepra mutilans
    Àý´Ü ³ª(ôîÓ¨ÑÛ)
  • neural leprosy
    ½Å°æ³ª.
  • neural leprosy
    ½Å°æ³ª(¡­³ª)
  • neural leprosy
    ½Å°æ³ª
  • nodular leprosy =tubercular l.
    °áÀý³ª(Ì¿ï½ ).
  • paucibacillary leprosy
    Èñ±Õ¼º³ª
  • polar lepromatous leprosy
  • rat leprosy
    ÁãÀÇ ³ªº´(¡­ÑÛÜ»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CME cervical mediastinal exploration; continuing medical education; Council on Medical Education; crude ...
EEM ectodermal dysplasia, ectrodactyly, macular dystrophy [syndrome]; erythema exudativum multiforme
FMC family medicine center; flight medicine clinic; focal macular choroidopathy; foundation for medical ...
JMD juvenile macular degeneration
ME macular edema; malic enzyme; manic episode; maximum effort; median eminence; medical education; medi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FTMH Full-thickness macular holes
MCD Macular corneal dystrophy
MP Macular pigment
SMD Senile macular degeneration
CMO cystoid macular oedema
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • macular hemangioma
    ¹ÝÁ¡¼º Ç÷°üÁ¾
  • macular pigmentation
    ¹ÝÁ¡¼º Âø»ö
  • macular ring reflex
    Ȳ¹Ý·û ¹Ý»ç
  • multibacillary leprosy
    ´Ù±Õ ³ªº´
  • mutilating leprosy
    Àý´Ü ³ª
  • nodular leprosy
    °áÀý ³ª
    µ¿ÀǾî=tubercular le
  • perifollicular macular atrophy
    ¸ð³¶ ÁÖÀ§ ¹Ý»ó À§Ãà
  • rat leprosy
    ÁãÀÇ ³ªº´
  • senile macular degeneration
    ³ë³â Ȳ¹Ý º¯¼º
    µ¿ÀǾî=age-related macular degeneration. ³ë³â±â¿¡ È£¹ßµÇ°í ¹Ý¼ö¿¡¼­ ¾ç¾È¼ºÀÌ¸ç ¼ºº° Â÷ÀÌ´Â ¾ø´Ù. ¸ÕÀú µå·çÁ¨À̳ª ºê·çÅ©¸·ÀÇ º¯¼ºÀÌ ¼±ÇàÇϸç À̵éÀÌ »ö¼Ò »óÇÇ º¯¼º°ú »ö¼Ò »óÇÇ ¹Ú¸®¸¦ ÀÏÀ¸Å°°í ¸Æ¶ô¸·¿¡¼­ Ç÷°ü ½Å»ýÀÌ »ý°Ü °¨°¢ ½Å°æ ¸Á¸· ¹Ø¿¡ ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ÀÌ·¯ÇÑ ÃâÇ÷ÀÌ ±âÁúÈ­µÇ¾î ¸Á¸· º¯¼ºÀ» ÀÏÀ¸Å°°Ô µÈ´Ù. Á᫐ ¾ÏÁ¡, ½Ã·Â Àå¾Ö, º¯½ÃÁõÀ» È£¼ÒÇÑ´Ù. ºê·çÅ©¸·ÀÇ º¯¼ºÀ̳ª ¸Á¸· »ö¼Ò ¹Ú¸®°¡ ÀÖÀ» ¶§ ±¤ÀÀ°í¸¦ Çϸé Ç÷°ü ½Å»ýÀÌ ÀÚ¶ó´Â °ÍÀ» ¸·À» ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lazarine leprosy An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
lepromatous leprosy A form of leprosy in which nodular cutaneous lesions are infiltrated, have ill-defined borders, and are bacteriologically positive; the lepromin test is negative, i.e., the immunologic mechanism of the patient is not responsive to the Mycobacterium leprae infection.
(05 Mar 2000)
leprosy <infectious disease> Caused by Mycobacterium leprae, an obligate intracellular parasite that survives lysosomal enzyme attack by possessing a waxy coat.
Leprosy is a chronic disease associated with depressed cellular (but not humoral) immunity, the bacterium requires a lower temperature than 37­C and thrives particularly in peripheral Schwann cells and macrophages.
Only humans and the nine banded armadillo are susceptible.
(18 Nov 1997)
leprosy bacillus A species of gram-positive, aerobic bacteria that causes leprosy in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
(12 Dec 1998)
leprosy, borderline A form of leprosy in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
(12 Dec 1998)
leprosy, lepromatous A chronic communicable infection which is a principal or polar form of leprosy. This disorder is caused by mycobacterium leprae and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.
(12 Dec 1998)
leprosy test <investigation> A test for leprosy where an extract of infected tissue (antigen) is injected under the skin to determine if you have a current or recent leprosy infection.
Normally, little or no skin reaction should result from the injection. A positive skin reaction indicates a leprosy infection.
(27 Sep 1997)
leprosy, tuberculoid A principal or polar form of leprosy in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy (leprosy, lepromatous), the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others.
(12 Dec 1998)
Lucio's leprosy An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
Lucio's leprosy phenomenon An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
macular Maculate
1. Relating to or marked by macules.
2. Denoting the central retina, especially the macula retinae.
(05 Mar 2000)
macular amyloidosis A localised form of amyloidosis cutis characterised by pruritic symmetrical brown reticulated macules, especially on the upper back; microscopically, amyloid is deposited as small subepidermal globules.
(05 Mar 2000)
macular area An oval area of the sensory retina, 3 by 5 mm, temporal to the optic disk corresponding to the posterior pole of the eye; at its centre is the central fovea, which contains only retinal cones.
Synonym: area centralis, macula lutea, macular area, punctum luteum, Soemmerring's spot, yellow spot.
(05 Mar 2000)
macular arteries See: inferior macular arteriole, superior macular arteriole.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á